Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Hebei Medical University Fourth Hospital
Chinese University of Hong Kong
University of California, San Francisco
New Mexico Cancer Research Alliance
The Wellcome Sanger Institute
The Wellcome Sanger Institute
The Wellcome Sanger Institute
National Cancer Institute (NCI)